Log in to save to my catalogue

Silk Fibroin-Based Therapeutics for Impaired Wound Healing

Silk Fibroin-Based Therapeutics for Impaired Wound Healing

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_534580a7d7c344299030a12157b1e8fd

Silk Fibroin-Based Therapeutics for Impaired Wound Healing

About this item

Full title

Silk Fibroin-Based Therapeutics for Impaired Wound Healing

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2022-03, Vol.14 (3), p.651

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Impaired wound healing can lead to local hypoxia or tissue necrosis and ultimately result in amputation or even death. Various factors can influence the wound healing environment, including bacterial or fungal infections, different disease states, desiccation, edema, and even systemic viral infections such as COVID-19. Silk fibroin, the fibrous str...

Alternative Titles

Full title

Silk Fibroin-Based Therapeutics for Impaired Wound Healing

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_534580a7d7c344299030a12157b1e8fd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_534580a7d7c344299030a12157b1e8fd

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14030651

How to access this item